Access to Breast Cancer Diagnosis Act of 2025
Latest action · Apr 28, 2025 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedApr 28, 2025
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Cosponsors 67
Members who signed on, in the order they did. Signatures ran from Apr 28, 2025 to Oct 29, 2026; 2 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-PA | Brian K. Fitzpatrick | Original | Apr 28, 2025 |
| D-FL | Debbie Wasserman Schultz | Original | Apr 28, 2025 |
| D-TX | Lloyd Doggett | Apr 29, 2025 | |
| D-WI | Gwen Moore | Jun 6, 2025 | |
| D-DC | Eleanor Holmes Norton | Jun 12, 2025 | |
| D-NM | Melanie A. Stansbury | Jun 20, 2025 | |
| D-MA | Seth Moulton | Jun 24, 2025 | |
| D-CT | Jahana Hayes | Jul 14, 2025 | |
| D-NY | Timothy M. Kennedy | Jul 23, 2025 | |
| D-VA | Jennifer L. McClellan | Aug 12, 2025 | |
| D-CT | John B. Larson | Aug 12, 2025 | |
| D-NY | Paul Tonko | Aug 12, 2025 | |
| D-NY | Yvette D. Clarke | Aug 12, 2025 | |
| D-MN | Angie Craig | Aug 22, 2025 | |
| R-NY | Michael Lawler | Aug 22, 2025 | |
| D-OH | Greg Landsman | Oct 3, 2025 | |
| R-PA | Robert P. Bresnahan, Jr. | Oct 3, 2025 | |
| D-IL | Robin L. Kelly | Oct 3, 2025 | |
| D-CA | Scott H. Peters | Oct 3, 2025 | |
| R-NJ | Thomas H. Kean, Jr. | Oct 3, 2025 | |
| R-TX | Beth Van Duyne | Oct 21, 2025 | |
| D-MI | Rashida Tlaib | Oct 21, 2025 | |
| D-MA | Stephen F. Lynch | Oct 24, 2025 | |
| D-WI | Mark Pocan | Nov 4, 2025 | |
| R-NY | Claudia Tenney | Nov 7, 2025 | |
| D-NJ | Josh Gottheimer | Nov 7, 2025 | |
| D-GA | Lucy McBath | Nov 7, 2025 | |
| R-CA | Young Kim | Nov 7, 2025 | |
| D-CO | Joe Neguse | Jan 12, 2026 | |
| D-MA | Lori Trahan | Jan 12, 2026 | |
| D-MD | Sarah Elfreth | Mar 24, 2026 | |
| D-CA | Nanette Diaz Barragán | Mar 26, 2026 | |
| D-MD | Jamie Raskin | Apr 13, 2026 | |
| D-WA | Kim Schrier | Apr 27, 2026 | |
| D-ME | Chellie Pingree | Apr 28, 2026 | |
| D-NY | Joseph D. Morelle | Apr 28, 2026 | |
| R-NY | Nick LaLota | Apr 28, 2026 | |
| D-TX | Julie Johnson | May 11, 2026 | |
| R-OH | Max L. Miller | May 11, 2026 | |
| D-NY | Daniel S. Goldman | Jun 2, 2026 | |
| D-NC | Donald G. Davis | Jun 2, 2026 | |
| D-PA | Chrissy Houlahan | Jun 15, 2026 | |
| D-NC | Deborah K. Ross | Jun 15, 2026 | |
| D-NJ | Jefferson Van Drew | Jun 15, 2026 | |
| D-MI | Haley M. Stevens | Jun 24, 2026 | |
| D-NM | Teresa Leger Fernandez | Jun 25, 2026 | |
| R-NE | Don Bacon | Jun 29, 2026 | |
| R-SC | Joe Wilson | Jun 29, 2026 | |
| D-AZ | Adelita S. Grijalva | Aug 17, 2026 | |
| D-OR | Janelle S. Bynum | Aug 17, 2026 | |
| D-NH | Maggie Goodlander | Aug 24, 2026 | |
| D-MI | Shri Thanedar | Aug 24, 2026 | |
| R-NY | Nicholas A. Langworthy | Aug 27, 2026 | |
| D-CA | Ted Lieu | Aug 27, 2026 | |
| R-NC | Chuck Edwards | Aug 31, 2026 | |
| D-VA | James R. Walkinshaw | Aug 31, 2026 | |
| D-PA | Madeleine Dean | Aug 31, 2026 | |
| R-WI | Derrick Van Orden | Sep 2, 2026 | |
| D-VA | Eugene Simon Vindman | Sep 2, 2026 | |
| D-WA | Adam Smith | Sep 10, 2026 | |
| R-PA | Ryan Mackenzie | Sep 10, 2026 | |
| D-MO | Wesley Bell | Sep 10, 2026 | |
| D-LA | Troy A. Carter | Sep 24, 2026 | |
| D-MA | James P. McGovern | Oct 5, 2026 | |
| D-OH | Joyce Beatty | Oct 6, 2026 | |
| D-NY | Josh Riley | Oct 29, 2026 | |
| D-CA | Julia Brownley | Oct 29, 2026 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Apr 28, 2025 |
| House | Ways and Means Committee | Referred Apr 28, 2025 |
Actions 2
Everything that happened, newest first.
- Apr 28, 2025Introduced in House
- Apr 28, 2025Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 171, no. 70, April 28, 2025, page H1684.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 1500 | Access to Breast Cancer Diagnosis Act of 2025 | Identical bill | Apr 28, 2025 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations.
- Short Title(s) as Introduced
- Access to Breast Cancer Diagnosis Act of 2025
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Apr 28, 2025Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
